STERIS Income from Continuous Operations 2010-2025 | STE

STERIS income from continuous operations for the twelve months ending June 30, 2025 was $0.650B, a 15.47% increase year-over-year.

  • STERIS annual income from continuous operations for 2025 was $0.612B, a 10.53% increase from 2024.
  • STERIS annual income from continuous operations for 2024 was $0.553B, a 0.52% decline from 2023.
  • STERIS annual income from continuous operations for 2023 was $0.556B, a 95.53% increase from 2022.

STERIS Income from Continuous Operations 2010-2025 | STE

  • STERIS annual income from continuous operations for 2025 was $0.612B, a 10.53% increase from 2024.
  • STERIS annual income from continuous operations for 2024 was $0.553B, a 0.52% decline from 2023.
  • STERIS annual income from continuous operations for 2023 was $0.556B, a 95.53% increase from 2022.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.9B
Intuitive Surgical (ISRG)$169.9B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.7B
Alcon (ALC)$39.2B
IQVIA Holdings (IQV)$32.1B
DexCom (DXCM)$29.4B
Mettler-Toledo (MTD)$26.4B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.8B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$8.1B
Masimo (MASI)$7.7B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$4B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1B